AF Gruppen subsidiary Strøm Gundersen has been selected to build the Krafttårnet and Generatoren buildings as part of phase two of the Drammen Helsepark project in Norway. The turnkey contract, valued ...
Novartis has announced plans to establish a 46,000-square-foot radioligand therapy manufacturing facility in Denton, Texas, with operations expected to begin in 2028. The new site will expand the ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する